Team find gene signature profile for metastasis

User rating: 5 / 5 after 4 vote(s)

A common signature of tiny, specific pieces of non-coding genetic material known as microRNAs (miRNAs) may be directly involved in the spread of cancer to other parts of the body. Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia and Ohio State University Medical Center in Columbus have identified such a signature, made up mostly of overexpressed miRNAs. The findings, reported at the annual meeting of the American Society of Clinical Oncology in Chicago, may represent a novel diagnostic tool in characterizing gene targets in metastatic cancer.


Full story »

All News summaries from Medicine & Health news
All News summaries for May 31, 2008

Researchers provide solution to world's worst mass poisoning case

2 hours ago | User rating: not rated yet
A solution to the world's worst case of ongoing mass poisoning, linked to rising cancer rates in Southern Asia, has been developed by researchers from Queen's University Belfast.

Common treatment to delay labor decreases preterm infants' risk for cerebral palsy

2 hours ago | User rating: not rated yet
Intravenous magnesium sulfate supplementation before preterm delivery cuts the risk for handicapping cerebral palsy in half, according to research led by University of Alabama at Birmingham (UAB) obstetrician Dwight Rouse, ...

Class of diabetes drugs carries significant cardiovascular risks

2 hours ago | User rating: not rated yet
A class of oral drugs used to treat type 2 diabetes may make heart failure worse, according to an editorial published online in Heart Wednesday by two Wake Forest University School of Medicine faculty members.

Tiny 3-D ultrasound probe guides catheter procedures

3 hours ago | User rating: not rated yet
An ultrasound probe small enough to ride along at the tip of a catheter can provide physicians with clearer real-time images of soft tissue without the risks associated with conventional x-ray catheter guidance.

Variation of normal protein could be key to resistance to common cancer drug

3 hours ago | User rating: not rated yet
Researchers at the Moores Cancer Center at the University of California, San Diego (UC SD) in La Jolla have found evidence explaining why a common chemotherapy drug, cisplatin, may not always work for every cancer patient. ...